Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Healthcare Medical Devices
Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight... see more

Recent & Breaking News (NDAQ:VANI)

Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System

Business Wire March 6, 2018

Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018

Business Wire March 5, 2018

Second Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference Call

Business Wire February 28, 2018

Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System

Business Wire February 16, 2018

Mid-Day Market Update: Dow Falls Over 250 Points; Enphase Energy Shares Spike Higher

Benzinga.com  February 5, 2018

Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant

Business Wire February 5, 2018

Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System

Business Wire December 5, 2017

Ontario Health Technology Advisory Committee Recommends Public Funding for Second Sight’s Argus II Retinal Prosthesis System

Business Wire November 10, 2017

Second Sight Receives FDA Expedited Access Pathway Designation for the Orion Cortical Visual Prosthesis System

Business Wire November 8, 2017

Second Sight Reports Third Quarter 2017 Financial Results

Business Wire November 2, 2017

Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical Study

Business Wire November 2, 2017

Second Sight Announces Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System

Business Wire November 2, 2017

Second Sight to Discuss Third Quarter 2017 Financial Results on November 2, 2017 Conference Call

Business Wire October 26, 2017

Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs

Business Wire October 19, 2017

Second Sight Receives Approval from Bundesinstitut für Arzneimittel und Medizinprodukte in Germany to Begin Study to Implant and Evaluate Argus II in Better-Sighted Retinitis Pigmentosa Patients

Business Wire October 17, 2017

Second Sight to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York on September 12th

Business Wire September 5, 2017

18 Biggest Mid-Day Gainers For Monday

Benzinga.com  August 28, 2017

Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study

Business Wire August 28, 2017

Second Sight Reports Second Quarter 2017 Financial Results

Business Wire August 1, 2017

Investor Network: Second Sight Medical Products, Inc. to Host Earnings Call

Accesswire August 1, 2017